2022 NHSN HAI Rebaseline Progress Tracker

New NHSN risk adjustment models based on the 2022 Rebaseline are being created in a phased approach. The 2022 NHSN HAI Rebaseline Progress Tracker provides the most up-to-date information regarding the status of the 2022 Rebaseline as the NHSN team moves through the various stages of the project. Please re-visit this page for regular updates on NHSN’s Rebaseline progress.

Stages of the 2022 HAI Rebaseline

Last updated 9/16/2024

Progress Stage

Progress Stage

Progress Stage

Description

Description

Description

Status

Status

Status

Planning

Progress Stage

Planning

  • Establishing the timeline, scope, roles, and plan for the 2022 HAI Rebaseline project.
  • Developing an initial communications and partner outreach strategy, including sharing preliminary plans with external partners such as the Centers for Medicare and Medicaid Services (CMS).
  • Freezing NHSN HAI data from 2022; preparing analytic datasets that will be used for subsequent modeling work.
Description
  • Establishing the timeline, scope, roles, and plan for the 2022 HAI Rebaseline project.
  • Developing an initial communications and partner outreach strategy, including sharing preliminary plans with external partners such as the Centers for Medicare and Medicaid Services (CMS).
  • Freezing NHSN HAI data from 2022; preparing analytic datasets that will be used for subsequent modeling work.

Stage Complete

Status

Stage Complete

Research

Progress Stage

Research

  • Conducting a literature review of recent studies that identified factors that are potentially associated, or not associated, with the incidence of HAIs.
  • Evaluating clinical significance of potential risk factors to inform risk adjustment decisions.
Description
  • Conducting a literature review of recent studies that identified factors that are potentially associated, or not associated, with the incidence of HAIs.
  • Evaluating clinical significance of potential risk factors to inform risk adjustment decisions.

Stage Complete

Status

Stage Complete

Analysis and Model Development

Progress Stage

Analysis and Model Development

  • Creating and validating new risk adjustment models.
  • Creating methodological standards to be applied across the development and validation of these statistical models.
  • Engaging with subject matter experts in review of model results.
Description
  • Creating and validating new risk adjustment models.
  • Creating methodological standards to be applied across the development and validation of these statistical models.
  • Engaging with subject matter experts in review of model results.

Stage Complete

Status

Stage Complete

Model Implementation

Progress Stage

Model Implementation

  • Developing standards and requirements for incorporating 2022 risk adjustment models into the NHSN application and datasets.
  • Testing and deploying analysis reports for new SIR and SUR models within the NHSN application.
Description
  • Developing standards and requirements for incorporating 2022 risk adjustment models into the NHSN application and datasets.
  • Testing and deploying analysis reports for new SIR and SUR models within the NHSN application.

In Progress

Status

In Progress

Education & Communication

Progress Stage

Education & Communication

  • Updating NHSN users and other stakeholders about the 2022 HAI Rebaseline project via blast email, the NHSN Newsletter, and/or other communication channels.
  • Developing content including Quick Reference Guides, webinars, websites, and Quick Learns to educate NHSN users and stakeholders about using and interpreting SIRs and SURs calculated under the new baseline.
Description
  • Updating NHSN users and other stakeholders about the 2022 HAI Rebaseline project via blast email, the NHSN Newsletter, and/or other communication channels.
  • Developing content including Quick Reference Guides, webinars, websites, and Quick Learns to educate NHSN users and stakeholders about using and interpreting SIRs and SURs calculated under the new baseline.

In Progress

Status

In Progress

Adoption, Integration, & Collaboration

Progress Stage

Adoption, Integration, & Collaboration

  • Ensuring that Federal, State, and other partners are informed and supported during the implementation of the new risk adjustment models.
  • Collaborating with Centers for Medicare and Medicaid Services (CMS) to work towards future adoption of the 2022 baseline SIRs into CMS programs.
  • Integrating new risk adjustment models into various CDC downstream products and publications, such as the National & State HAI Progress Report.
Description
  • Ensuring that Federal, State, and other partners are informed and supported during the implementation of the new risk adjustment models.
  • Collaborating with Centers for Medicare and Medicaid Services (CMS) to work towards future adoption of the 2022 baseline SIRs into CMS programs.
  • Integrating new risk adjustment models into various CDC downstream products and publications, such as the National & State HAI Progress Report.

In Progress

Status

In Progress

Model Implementation: Availability of SIR and SUR Reports in NHSN

Last updated 9/16/2024

New SIR and SUR reports will be built in the NHSN application as part of the 2022 HAI Rebaseline. These reports will provide NHSN users with SIR and SUR values calculated using new risk adjustment models. Use the table below to view the current status and progress in the development of these new analysis reports in NHSN.

SIR/SUR Reports (2022 Baseline) Available in NHSN

SIR/SUR Reports (2022 Baseline) Available in NHSN

SIR/SUR Reports (2022 Baseline) Available in NHSN

SIR/SUR Reports (2022 Baseline) Under Development in NHSN

SIR/SUR Reports (2022 Baseline) Under Development in NHSN

SIR/SUR Reports (2022 Baseline) Under Development in NHSN

Please stay tuned for 2022 baseline reports coming to NHSN later this year.

SIR/SUR Reports (2022 Baseline) Available in NHSN

Please stay tuned for 2022 baseline reports coming to NHSN later this year.

  • CLABSI and MBI-LCBI
  • CAUTI
  • CDI LabID
  • MRSA Blood LabID
  • VAE and pedVAE
  • SSI – Complex 30-day
  • SSI – Complex Admission/Readmission
  • SSI – All SSI
  • SUR models
SIR/SUR Reports (2022 Baseline) Under Development in NHSN
  • CLABSI and MBI-LCBI
  • CAUTI
  • CDI LabID
  • MRSA Blood LabID
  • VAE and pedVAE
  • SSI – Complex 30-day
  • SSI – Complex Admission/Readmission
  • SSI – All SSI
  • SUR models